This study presents a novel mechanism of EZH2 action in MM pathogenesis by regulating the expression of miRNA genes with tumor suppressor functions and further supports the notion of EZH2 as potential therapeutic target in MM also indirectly affecting the expression of MM-associated oncogenes. This evidence concerns the gene EZH2 and Miyoshi myopathy.